COLTENE Holding AG (SWX:CLTN)
Switzerland · Delayed Price · Currency is CHF 49.90
-0.30 (-0.60%)
At close: Nov 28, 2025
COLTENE Holding AG Revenue
COLTENE Holding AG had revenue of 118.05M CHF in the half year ending June 30, 2025, a decrease of -10.18%. This brings the company's revenue in the last twelve months to 240.71M, up 0.80% year-over-year. In the year 2024, COLTENE Holding AG had annual revenue of 250.16M with 3.06% growth.
Revenue (ttm)
240.71M
Revenue Growth
+0.80%
P/S Ratio
1.24
Revenue / Employee
204.68K
Employees
1,251
Market Cap
298.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 250.16M | 7.43M | 3.06% |
| Dec 31, 2023 | 242.73M | -24.40M | -9.13% |
| Dec 31, 2022 | 267.13M | -12.12M | -4.34% |
| Dec 31, 2021 | 279.24M | 30.89M | 12.44% |
| Dec 31, 2020 | 248.35M | -25.48M | -9.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 44.95B |
| Sandoz Group AG | 8.42B |
| Alcon | 8.12B |
| Lonza Group AG | 7.09B |
| Galenica AG | 4.03B |
| Sonova Holding AG | 3.85B |
| Galderma Group AG | 3.73B |